» Articles » PMID: 39509356

Comparing the Brief Holistic Health for HIV (3H+) to the Holistic Health Recovery Program (HHRP+) Among People with HIV and Opioid Use Disorder: Results from a Randomized, Controlled Non-inferiority Trial

Overview
Journal PLoS One
Date 2024 Nov 7
PMID 39509356
Authors
Affiliations
Soon will be listed here.
Abstract

Few evidence-based interventions have been widely adopted in common clinical settings, particularly for opioid-dependent people with HIV (PWH) seeking drug treatment. We developed a brief evidence-based intervention, Holistic Health for HIV (3H+), specifically for ease of implementation and integration within drug treatment settings. In this study, we compared 3H+ to the gold standard, Holistic Health Recovery Program (HHRP+) using a non-inferiority trial. Between 2012 and 2017, 106 participants were randomly assigned to either the brief 3H+ intervention or the gold standard HHRP+. HIV treatment (ART adherence, viral suppression) and risk behaviors (sharing injection equipment, condom use) were compared between the two arms at baseline, end-of-intervention (EOI-12 weeks) and at follow-up (24 weeks). Average treatment effect was calculated based on the difference-in-difference (DID) estimator and a non-parametric bootstrap was used to assess non-inferiority. At the 12-week EOI point, 3H+ was found to be non-inferior to HHRP+ with respect to multiple outcomes: percent sharing syringes and needles (DID:1.4, 95%CI [-18.6,21.5], p<0.01) and attainment of high ART adherence (DID: 9.7, 95%CI: [-13.1, 32.2], p = 0.04). At the 24-week EOI point, 3H+ was found to be non-inferior to HHRP+ with respect to percent sharing syringes and needles (DID: 8.9, [-10.1, 28.30], p = 0.04) and attainment of viral suppression (DID: 18.9, 95% CI:[-7.1, 42.0], p = 0.01). For other indicators, such as consistent condom use, the hypothesis test for non-inferiority was inconclusive at the 12-week EOI (DID: -20.2, 95%CI [-48.9-10.7], p = 0.51). For HIV treatment as prevention to be effective, PWH need to achieve viral suppression. In the absence of this success, they must reduce HIV risk behaviors. The finding that 3H+ was non-inferior to HHRP+ suggests that brief behavioral interventions can be deployed in real world settings to help more efficiently achieve Ending the HIV Epidemic goals.

References
1.
Perlman D, Jordan A . The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions. Curr HIV/AIDS Rep. 2018; 15(2):96-112. PMC: 5884743. DOI: 10.1007/s11904-018-0390-3. View

2.
Morgenstern J, Morgan T, McCrady B, Keller D, Carroll K . Manual-guided cognitive-behavioral therapy training: a promising method for disseminating empirically supported substance abuse treatments to the practice community. Psychol Addict Behav. 2001; 15(2):83-8. View

3.
Oesterle T, Kolla B, Risma C, Breitinger S, Rakocevic D, Loukianova L . Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook. Mayo Clin Proc. 2020; 95(12):2709-2718. PMC: 7577694. DOI: 10.1016/j.mayocp.2020.10.011. View

4.
Eller A, DiDomizio E, Madden L, Oliva J, Altice F, Johnson K . Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection. Ann Med. 2022; 54(1):1714-1724. PMC: 9377256. DOI: 10.1080/07853890.2022.2084154. View

5.
Turner C, Ku L, Rogers S, Lindberg L, Pleck J, Sonenstein F . Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998; 280(5365):867-73. DOI: 10.1126/science.280.5365.867. View